MeSH Browser

MeSH Heading: Rituximab
Tree Number(s): D12.776.124.486.485.114.224.075.785; D12.776.124.790.651.114.224.075.785; D12.776.377.715.548.114.224.284.785
Unique ID: D000069283
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D000069283
Scope Note: A murine-derived monoclonal antibody and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS.
Entry Term(s): CD20 Antibody, Rituximab; GP2013; IDEC-C2B8; IDEC-C2B8 Antibody; Mabthera; Rituxan
Pharm Action: Immunologic Factors
Antirheumatic Agents
Antineoplastic Agents, Immunological
Related Numbers: 174722-31-7
See Also: Antigens, CD20
Public MeSH Note: 2016; RITUXIMAB was indexed under ANTIBODIES, MONOCLONAL, MURINE-DERIVED 1995-2016
History Note: 2016 (1995)
Date Established: 2016/01/01
Date of Entry: 2015/07/01
Revision Date: 2020/05/27

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

analysis (AN)

biosynthesis (BI)

blood (BL)

cerebrospinal fluid (CF)

chemistry (CH)

classification (CL)

drug effects (DE)

economics (EC)

genetics (GE)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

physiology (PH)

poisoning (PO)

radiation effects (RE)

therapeutic use (TU)

toxicity (TO)

ultrastructure (UL)

urine (UR)

Rituximab MeSH Descriptor Data 2024